<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="318">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05157009</url>
  </required_header>
  <id_info>
    <org_study_id>VerdugoF</org_study_id>
    <nct_id>NCT05157009</nct_id>
  </id_info>
  <brief_title>Immediate Implant Outcomes With and Without Bone Augmentation</brief_title>
  <official_title>Immediate Implants in Damaged Sockets With Simultaneous Bone Reconstruction vs. Immediate Implants in Intact Sockets and no Reconstruction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Verdugo, Fernando, DDS</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Verdugo, Fernando, DDS</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate immediate implant placement feasibility and esthetic outcomes in severely damaged&#xD;
      sockets that received simultaneously bone reconstruction (cortical bone shield) and implant&#xD;
      placement versus intact sockets that needed no reconstruction and had immediate implant&#xD;
      placement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present clinical trial aims at demonstrating facial bone regeneration on sites that&#xD;
      presented large buccal bone dehiscences &amp; vertical bone loss and evaluate the feasibility of&#xD;
      performing simultaneous bone augmentation and implant placement, comparing the outcomes with&#xD;
      sites that had intact sockets that did not require reconstruction. A secondary objective was&#xD;
      to evaluate pink esthetics and marginal bone levels at final follow-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate implant placement feasibility &amp; success rate at 12 months</measure>
    <time_frame>12 months</time_frame>
    <description>evaluate implant success following Karoussis et al. success criteria</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of individuals with low pink esthetic outcomes as assessed by pink esthetic scores</measure>
    <time_frame>12 months</time_frame>
    <description>pink esthetics scores (PES) as proposed by Belser et al.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Presence or absence of implant transparency</measure>
    <time_frame>12 months</time_frame>
    <description>evaluate facial mucosal implant transparency at 12 months: positive or negative</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with &gt;0.2mm of marginal bone levels</measure>
    <time_frame>12 months</time_frame>
    <description>evaluate radiographic marginal bone levels at 12 months with &gt;0.2mm of bone loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence or absence of a band of keratinized tissue</measure>
    <time_frame>12 months</time_frame>
    <description>evaluate the presence of facial keratinized tissue on the implant sites &gt;2 or &lt;2mm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tooth Loss</condition>
  <condition>Bone Loss, Alveolar</condition>
  <condition>Dental Diseases</condition>
  <condition>Dental Trauma</condition>
  <arm_group>
    <arm_group_label>Immediate implant placement without reconstruction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Immediate implant placement after tooth extraction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immediate implant placement with reconstruction</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Immediate implant placement and simultaneous bone reconstruction after tooth extraction</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>implant placement</intervention_name>
    <description>autogenous bone reconstruction of damaged socket &amp; simultaneous implant placement</description>
    <arm_group_label>Immediate implant placement with reconstruction</arm_group_label>
    <arm_group_label>Immediate implant placement without reconstruction</arm_group_label>
    <other_name>bone reconstruction</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  individuals 20 Years and older&#xD;
&#xD;
          -  Patients requiring single implants to replace missing teeth to restore masticatory&#xD;
             function and esthetics.&#xD;
&#xD;
          -  ASA1 or ASA2 (American Society of Anesthesiologists)&#xD;
&#xD;
          -  Healthy individuals with good oral hygiene and motivation&#xD;
&#xD;
          -  No systemic uncontrolled diseases&#xD;
&#xD;
          -  Not taking drugs known to modify bone metabolism&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals with untreated &amp; generalized severe periodontitis&#xD;
&#xD;
          -  Smokers (&gt;5 cigarettes/day)&#xD;
&#xD;
          -  Poor oral hygiene&#xD;
&#xD;
          -  Diabetes (HbA1C &gt;6.5% as cutoff value)&#xD;
&#xD;
          -  Uncontrolled cardiovascular disease&#xD;
&#xD;
          -  Poor overall health (ASA IV)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Verdugo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Verdugo, Fernando, DDS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>FV, DDS,Corp</name>
      <address>
        <city>San Gabriel</city>
        <state>California</state>
        <zip>91776</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 8, 2021</study_first_submitted>
  <study_first_submitted_qc>November 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 14, 2021</study_first_posted>
  <last_update_submitted>November 30, 2021</last_update_submitted>
  <last_update_submitted_qc>November 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>immediate dental implant</keyword>
  <keyword>dental implant</keyword>
  <keyword>bone regeneration</keyword>
  <keyword>peri-implantitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alveolar Bone Loss</mesh_term>
    <mesh_term>Tooth Loss</mesh_term>
    <mesh_term>Stomatognathic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

